Thus, we hypothesize that in neuroinflammatory diseases such as MS and X-ALD, CES1 levels might be increased in pro-inflammatory lipid-laden phagocytes that accumulate in the lesion area, possibly further augmenting the selectivity of tefinostat for pro-inflammatory foamy macrophages. The gene discussed is CES1; the disease is myeloid sarcoma.